EMSY Antibodies

Santa Cruz Biotechnology supplies a comprehensive collection of EMSY Antibodies for research focused on understanding EMSY's role in cellular processes. EMSY Antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). EMSY plays a critical role in DNA repair and transcription regulation, making it significant in cancer biology and diseases associated with genomic instability. EMSY's involvement in modulating gene expression and protein interactions highlights its importance in cellular processes. Research has shown that EMSY functions as a transcriptional regulator, influencing various pathways involved in cell growth and development. Understanding EMSY's mechanisms can reveal new insights into cancer development and potential therapeutic strategies. Recent studies have highlighted EMSY's role in breast cancer progression and its potential as a biomarker. Investigating EMSY's functions in different cellular contexts continues to expand our knowledge of disease mechanisms. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of EMSY's role in health and disease.